🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesAdiponectin and leptin changes on GLP-1 therapy — what worked for you? Page 4

Adiponectin and leptin changes on GLP-1 therapy — what worked for you?

bri_stats Fri, Sep 19, 2025 at 5:59 AM 39 replies 1,546 viewsPage 4 of 8
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Sep 19, 2025 at 11:39 AM#16

Just wanted to say — for anyone reading this Adiponectin and thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

12 22josh_phd_bmore, roxy_nash, tony_orlando and 9 others
Reply Quote Save Share Report
SaraMom3
Member
456
2,345
Aug 2024
Ohio
Sep 19, 2025 at 11:56 AM#17

bri_stats's experience with Adiponectin and leptin resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 42 lbs in 7 months.

One thing I would add that bri_stats did not mention: the mental health improvements were just as significant.

30 5ChrisMacros, KetoKyle, CanadaChris and 27 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Sep 19, 2025 at 12:13 PM#18

Saving this for reference. Top-tier content.

15 9FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 12 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Sep 19, 2025 at 12:30 PM#19

As a pharmacist, I want to add some clinical context to this discussion on Adiponectin and leptin changes on GLP-1.

Building on what bri_stats said — the evidence base here is robust. The key publications to reference are from the FLOW program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
2 4tony_orlando, Dr.NephBHM_UK
Reply Quote Save Share Report
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Sep 19, 2025 at 12:47 PM#20

Subscribing to this thread. Adiponectin and leptin is exactly what I've been researching. 🙏

Last edited: Sep 19, 2025 at 2:47 PM
22 18DataDave, Dr.GutHealth, amsterdam_pete and 19 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register